WisdomSpan Press

Behind the Curtain / Research companion

Follow the evidence.

Explore the 200-note reference archive, six research tools, and the current 40-figure caption index.

Updated September 9, 2026 for the revised manuscript. The archive distinguishes contemporary records, attributed reporting, historical interpretation, and reform proposals.

Source archive

Search by note number, person, subject, or source. A cited account may establish what was reported without independently establishing that the event occurred as described. Check each annotation and the underlying source.

200 notes

Note 1

Presidential media availability. Alex Thompson, “Biden’s Media Evasion,” Axios, July 3, 2024; and Alex Thompson, “Inside Biden’s Media Evasion,” Axios, July 4, 2024. Axios, using data from presidential scholar Martha Joynt Kumar, reported that Biden had conducted fewer press conferences and interviews than the six presidents immediately preceding him at comparable points, while also noting that he participated in many short informal reporter exchanges. Axios analysis.

Note 2

George Clooney’s public call for withdrawal. Will McDuffie, “George Clooney, Who Co-Hosted Recent Biden Fundraiser, Says President Should Step Aside,” ABC News, July 10, 2024, summarizing Clooney’s New York Times guest essay. The source supports that Clooney was a recent fundraiser co-host and publicly urged Biden to leave the race after describing concern about the president he observed. ABC News.

Note 3

Reported fundraiser-recognition anecdote. Alex Thompson, “Biden Didn’t Recognize George Clooney at Fundraiser: New Book,” Axios, May 13, 2025, reporting an account in Jake Tapper and Alex Thompson’s Original Sin. This source verifies that the allegation was published and attributed to the book; it does not independently establish that the event occurred exactly as described. Axios.

Note 4

The 2024 presidential physical and cognitive testing. Kevin C. O’Connor, D.O., “President Biden’s Current Health Summary,” Physician to the President, February 28, 2024; Aamer Madhani and Darlene Superville, “Biden ‘Continues to Be Fit for Duty,’ His Doctor Says,” Associated Press, February 28, 2024; Deepa Shivaram, “Biden Just Got a Physical. But a Cognitive Test Was Not Part of the Assessment,” NPR/WBUR, February 28, 2024; and Meredith Deliso, “Biden Won’t Commit to Independent Cognitive Test,” ABC News, July 6, 2024. The official memorandum documented specialist review, including neurology, and a detailed neurologic examination; contemporaneous reporting stated that no separate formal cognitive screening test was included. Official 2024 health summary; AP; WBUR/NPR; ABC News.

Note 5

Autopen legality and the separate authorization question. U.S. Department of Justice, Office of Legal Counsel, “Whether the President May Sign a Bill by Directing That His Signature Be Affixed to It,” July 7, 2005; Lisa Mascaro, Associated Press, reporting on the House investigation, October 21, 2025; and Nik Popli, “How the Autopen Earned Trump’s Ire,” TIME, July 2025. The OLC opinion supports the legality of a president directing that a signature be affixed by autopen. It does not resolve whether a particular act was actually authorized—a separate factual question that remained contested in the Biden inquiry. DOJ OLC opinion; AP; TIME.

Note 6

Biden’s prostate-cancer diagnosis and PSA history. Reuters, “Former U.S. President Biden Diagnosed with ‘Aggressive’ Prostate Cancer,” May 18–19, 2025; Reuters, “Biden Had Not Received Prostate Cancer Screening Since 2014, Spokesperson Says,” May 20, 2025; and Associated Press, “Biden’s Office Says His ‘Last Known’ Prostate Cancer Screening Was in 2014,” May 20, 2025. These sources report an aggressive, hormone-sensitive prostate cancer with bone metastasis and the statement from Biden’s office that his last known PSA screening was in 2014. They do not establish when the cancer began or that a particular earlier test would certainly have detected it. Reuters—diagnosis; Reuters—PSA history; AP.

Note 7

PSA-screening guidance for older men. See notes 46–47 for the USPSTF and AUA/SUO guidance used throughout the manuscript. The book’s proposed presidential protocol is an original policy position, not current guideline-mandated care.

Note 8

Dr. David Shusterman’s public medical commentary. “Biden Likely Knew He Had Cancer for a Long Time: Urologist,” NewsNation Prime, May 2025; “Doctor Talks Prostate Cancer, Free Blood Tests,” Spectrum News NY1, May 28, 2025; and “Does Not Make Sense: Urologist Analyzes Biden’s Cancer Diagnosis,” The Evening Edit, May 2025. These appearances document Dr. Shusterman’s public position that the advanced presentation raised questions about the disease timeline and the absence of a disclosed longitudinal PSA record. Those statements are expert interpretation, not proof that Biden or his physicians knew of the cancer earlier. NewsNation interview; NY1; The Evening Edit interview.

Note 9

Dr. Kevin O’Connor’s congressional testimony. House Committee on Oversight and Government Reform, deposition transcript and released video, July 9, 2025; Lauren Peller, Katherine Faulders, and Alexandra Hutzler, “Oversight Committee Releases Video of Biden’s Physician’s Closed-Door Testimony,” ABC News, July 9, 2025. O’Connor declined to answer committee questions and asserted both medical confidentiality or physician-patient privilege and the Fifth Amendment. His counsel identified a parallel criminal investigation as a basis for the Fifth Amendment invocation and stated that invocation is not an admission of wrongdoing. The invocation itself is not medical evidence of prior diagnosis, malpractice, concealment, or an adverse medical fact. Official transcript; official video release; ABC News.

Note 10

Jill Biden’s later account of the 2024 debate. “Jill Biden Says She Was ‘Frightened’ by Joe Biden’s 2024 Debate Performance, Thought He Was Having a Stroke,” CBS News, May 27, 2026; and “Jill Biden Says Joe Biden ‘Was Slowing Down’ but Wasn’t in Cognitive Decline,” CBS News, May 28, 2026. These reports support that she later described acute fear during the debate while also denying that she had observed cognitive decline. Her recollection is evidence of what she feared at the time, not clinical evidence that a stroke occurred. CBS News—debate recollection; CBS News—cognitive-decline denial.

Note 11

Post-debate Democratic concern and withdrawal. “Increasing Numbers of Voters Don’t Think Biden Should Be Running After Debate,” CBS News, July 1, 2024; “Over Half of Dems Say Biden Should Drop Out After Debate,” Politico, July 11, 2024; and “Read Biden’s Full Letter Announcing the End of His 2024 Reelection Bid,” PBS NewsHour, July 21, 2024. These sources document increased concern within the Democratic electorate, mounting pressure, and Biden’s eventual withdrawal. They do not establish that every party leader possessed the same information or knowingly concealed incapacity. CBS News poll; Politico; PBS NewsHour.

Note 12

HIPAA and legally authorized disclosure. See notes 55 and 79–80 for the ethical, HIPAA, and Privacy Act framework. HIPAA is neither an absolute bar nor a general public-disclosure mandate; any presidential-health system requires specific lawful authority and safeguards.

Note 13

The founding generation, illness, and retrospective diagnosis. National Park Service, “Disability History: Presidents and Disability”; George Washington’s Mount Vernon, historical material on Washington’s illnesses and death; and biographical records concerning Jefferson, Franklin, Madison, and Adams. These sources support that major founders lived with serious illness and disability. Retrospective labels—especially epilepsy, depression, hypertension, or psychosomatic illness—remain uncertain unless the historical record is explicit. NPS; Mount Vernon—Washington’s final illness.

Note 14

Washington’s retirement and Farewell Address. George Washington, “Farewell Address,” September 19, 1796; National Constitution Center, “Farewell Address (1796).” Washington wrote that “choice and prudence” invited him to leave political life and that patriotism did not forbid it. The address supports voluntary retirement and peaceful transfer, but it does not say that declining medical capacity compelled his departure. Primary text; National Constitution Center.

Note 15

Jefferson’s public-trust and health statements. U.S. Department of the Interior, “Basic Obligation of Public Service”; Thomas Jefferson to Peter Carr, August 10, 1787, as reproduced by Encyclopedia Virginia; and Lyndon B. Johnson’s 1965 health message quoting Jefferson. The “public property” statement expresses public-service ethics but does not itself establish surrender of medical privacy. The health statement was personal advice, not a constitutional medical-disclosure rule. Interior Department; Jefferson to Peter Carr; Presidency Project.

Note 16

The Constitution and presidential inability. U.S. Constitution Annotated, Twenty-Fifth Amendment; Gerald R. Ford Presidential Library, “The Establishment and First Uses of the 25th Amendment.” The original Constitution left central disability questions unresolved. Congress proposed the Twenty-Fifth Amendment in 1965, and the states completed ratification in 1967. Constitution Annotated; Ford Library.

Note 17

Biden’s 1987 withdrawal and 1988 aneurysm sequence. Michael Kranish, “Biden Once Nearly Died of an Aneurysm,” The Washington Post, May 14, 2024; Lois Romano, “The Second Life of Joe Biden,” The Washington Post, January 11, 1989; and “Biden’s Medical History Not Scrutinized,” CBS News, October 18, 2008. Biden withdrew from the presidential race in September 1987. In February 1988, after a Rochester episode, he returned to Delaware, was evaluated at St. Francis Hospital, and was transferred to Walter Reed after bleeding and an aneurysm were identified. 2024 reconstruction; 1989 profile; CBS News.

Note 18

Biden’s operations, pulmonary embolism, and recovery. Contemporary and later accounts report clipping of a leaking or ruptured aneurysm, discovery and later clipping of a second unruptured aneurysm, a pulmonary embolism during recovery, and an absence from normal Senate work for roughly six months. Treating surgeon Neal Kassell has said the bleeding did not enter brain tissue and that Biden sustained no brain damage. The record supports a severe medical crisis and a reported successful recovery; it does not establish later cognitive impairment. Washington Post reconstruction; Brain Aneurysm Foundation.

Note 19

Long-term outcomes after aneurysmal subarachnoid hemorrhage. Al-Khindi, Macdonald, and Schweizer, “Cognitive and Functional Outcome After Aneurysmal Subarachnoid Hemorrhage,” Stroke (2010); and recent clinical reviews of cognitive outcomes after aneurysmal subarachnoid hemorrhage. Survivors may experience deficits involving memory, executive function, attention, language, fatigue, mood, or quality of life even after functional independence. Rates vary markedly by cohort, hemorrhage severity, treatment, complications, and assessment method. These population findings cannot be assigned to Biden without individual data. PubMed; 2024 review.

Note 20

Clipping, coiling, and cognitive outcomes. Scott et al., “Improved Cognitive Outcomes with Endovascular Coiling of Anterior Communicating Artery Aneurysms Compared with Neurosurgical Clipping,” and related long-term studies. Some research identifies early or domain-specific differences, while other studies find minimal long-term cognitive differences after accounting for clinical factors. The literature does not support a categorical claim that clipping causes permanent cognitive impairment or that Biden developed postoperative neurocognitive disorder. PubMed.

Note 21

Pulmonary embolism and post-PE burden. European Society of Cardiology and peer-reviewed literature on post-pulmonary-embolism syndrome and chronic thromboembolic pulmonary hypertension. Survivors may report dyspnea, fatigue, anxiety, reduced exercise tolerance, or impaired quality of life; chronic thromboembolic pulmonary hypertension develops in a minority. These data do not establish that Biden had chronic hypoxia or later cognitive injury. ESC clinical overview.

Note 22

Roosevelt’s disability and late cardiovascular disease. Franklin D. Roosevelt Presidential Library and National Park Service materials document Roosevelt’s polio-related paralysis, the management of public images, and a 1944 evaluation showing severe hypertension, cardiomegaly, and congestive heart failure. Roosevelt’s mobility disability did not itself establish incapacity; the separate heart-disease history raises the disclosure issue. FDR Library; NPS—The Dying President.

Note 23

Kennedy’s medical history and medications. Robert Dallek and later medical-record reviews document adrenal insufficiency/Addison’s disease, hypothyroidism, chronic back pain, steroid treatment, pain medication, sedatives, stimulants, and injections from Max Jacobson. The records support extensive undisclosed illness and treatment burden. They do not prove that a specific drug determined a particular presidential decision. PBS NewsHour; PubMed medical review.

Note 24

Reagan and the disputed onset of Alzheimer’s disease. Ronald Reagan, public letter announcing Alzheimer’s disease, November 5, 1994; Lawrence K. Altman’s reporting on Reagan’s doctors and aides; Berisha et al., “Tracking Discourse Complexity Preceding Alzheimer’s Disease Diagnosis”; and Matthew Beckmann, “Did Reagan Decline?” Reagan’s diagnosis is established. Whether clinically meaningful dementia affected his presidency remains disputed. Retrospective speech analysis can generate hypotheses but cannot establish an individual diagnosis or constitutional incapacity. Reagan Library letter; STAT; PMC linguistic study.

Note 25

Nixon, alcohol, and military-order precautions. National Security Archive, “Kissinger Told Soviet Envoy during 1973 Arab-Israeli War,” including a telephone record in which Kissinger said Nixon was “loaded”; and historical reporting on James Schlesinger’s alleged precautions during the final Watergate period. The Kissinger statement is documented. The broader Schlesinger account lacks complete corroborating documentation and should remain attributed. National Security Archive; TIME historical analysis.

Note 26

Trump’s health letters and 2020 COVID-19 hospitalization. Harold Bornstein later said Trump dictated the unusually laudatory 2015 health letter. During the October 2020 hospitalization, Trump’s medical team acknowledged two episodes of low oxygen and treatment with oxygen, remdesivir, dexamethasone, and an investigational monoclonal antibody. Briefings were criticized for incomplete and changing accounts. These facts support a transparency critique, not an unsupported claim that Trump was near mechanical ventilation. Bornstein account; TIME medical briefing.

Note 27

Biden, Hur, and the 2024 credibility dispute. Robert K. Hur, “Report on the Investigation Into Unauthorized Removal, Retention, and Disclosure of Classified Documents Discovered at Locations Including the Penn Biden Center and the Delaware Private Residence of President Joseph R. Biden, Jr.,” February 2024; White House reporting on the 2024 physical; and Sanjay Gupta’s post-debate call for detailed neurological and cognitive evaluation. Hur’s language concerned prosecutorial judgment and anticipated jury perception, not a medical diagnosis. Hur report; 2024 health summary; CNN/Sanjay Gupta.

Note 28

Books and attributed allegations about Biden’s decline. Franklin Foer, The Last Politician (2023), and Jake Tapper and Alex Thompson, Original Sin (2025). These works provide reported accounts from named and unnamed sources. Claims about recognition failures, restricted access, discussion of wheelchair use, or staff management must remain explicitly attributed and should not be presented as independently established clinical facts.

Note 29

Normal cognitive aging. Harada, Natelson Love, and Triebel, “Normal Cognitive Aging,” Clinics in Geriatric Medicine (2013); and National Institute on Aging, “How the Aging Brain Affects Thinking.” Average aging is associated with slower processing and changes in some memory and executive functions, but trajectories vary substantially and many abilities remain preserved. Age does not determine individual capacity. PubMed; NIA.

Note 30

Executive-function constructs. Adele Diamond, “Executive Functions,” Annual Review of Psychology (2013). Executive function includes separable but related processes such as inhibitory control, working memory, and cognitive flexibility. The article supports the domain framework; it does not establish a validated presidential-fitness battery. PubMed.

Note 31

Acute stress and cognition. Shields, Sazma, and Yonelinas, “The Effects of Acute Stress on Core Executive Functions,” Neuroscience & Biobehavioral Reviews (2016). The meta-analysis found average impairment in working memory and cognitive flexibility, with more nuanced effects on inhibition. Stress effects vary by task and context; cortisol should not be treated as a universal one-direction explanation. PubMed.

Note 32

Decision fatigue. Pignatiello, Martin, and Hickman, “Decision Fatigue: A Conceptual Analysis” (2020), and Maier et al., systematic review (2025). The concept is plausible and used across health research, but definitions and consequences have been heterogeneous. The manuscript therefore uses broader terms—cognitive load, mental fatigue, stress, and sleep loss—rather than claiming a fixed number of decisions predictably causes poor judgment. PubMed; Systematic review.

Note 33

Sleep loss and executive function. Killgore, “Effects of Sleep Deprivation on Cognition” (2010); and Cao, Xie, and Ma, meta-analysis of working memory, inhibition, and cognitive flexibility (2025). Sleep loss impairs multiple cognitive functions on average, but magnitude and presentation vary across people and tasks. PubMed; 2025 meta-analysis.

Note 34

MoCA and MMSE. Nasreddine et al., “The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool for Mild Cognitive Impairment” (2005); Folstein, Folstein, and McHugh, “‘Mini-Mental State’: A Practical Method for Grading the Cognitive State of Patients for the Clinician” (1975). Both are brief screens. Neither was developed or validated as a complete occupational-capacity test for the presidency. MoCA; MMSE.

Note 35

Population screening evidence. U.S. Preventive Services Task Force, “Cognitive Impairment in Older Adults: Screening” (2020). For asymptomatic community-dwelling adults sixty-five and older, the USPSTF concluded that evidence was insufficient to assess the balance of benefits and harms of routine screening. The proposed presidential protocol is an original high-consequence occupational policy, not current general-population guidance. USPSTF.

Note 36

Mild cognitive impairment. Petersen et al., American Academy of Neurology practice-guideline update (2018); National Institute on Aging, “What Is Mild Cognitive Impairment?” MCI is heterogeneous and does not equal dementia or presidential incapacity. Reversible contributors and longitudinal course matter. Guideline; NIA.

Note 37

Cognitive reserve and exceptional aging. Tucker and Stern, “Cognitive Reserve in Aging” (2011); Powell et al., systematic review of cognitive super-aging (2023). Reserve is a probabilistic resilience construct, not a measurable fuel supply that predictably collapses. Some older adults retain exceptional cognitive performance. Reserve; Super-aging.

Note 38

Medical decision-making capacity. Appelbaum and Grisso, “Assessing Patients’ Capacities to Consent to Treatment” (1988), and the MacCAT-T literature. Clinical capacity commonly examines the abilities to communicate a choice, understand information, appreciate consequences, and reason about options. The framework is task-specific but is not itself a presidential constitutional standard. PubMed; MacCAT-T.

Note 39

Ecological validity of executive testing. Chaytor and Schmitter-Edgecombe, “The Ecological Validity of Neuropsychological Tests” (2003); Suchy, “Conceptualization of the Term Ecological Validity” (2024); and Suchy et al., systematic review of novel executive tests (2024). Traditional tests often predict real-world function only imperfectly, while a realistic-looking task is not automatically validated. 2003 review; 2024 concept review; 2024 systematic review.

Note 40

Longitudinal testing, practice effects, and reliable change. Duff, “Practice Effects: A Unique Cognitive Variable” (2012); Cooley et al., longitudinal MoCA study (2015); and Gavett et al., reliable-change methods (2015). Repeated testing can improve scores through familiarity, and apparent change should be interpreted using alternate forms, measurement error, and reliable-change methods. Practice effects; MoCA longitudinal change; Reliable change.

Note 41

Sensory access and cognitive testing. Nichols et al., “Assessing Bias in Cognitive Testing for Older Adults with Sensory Impairment” (2022); and Kim et al., test-modality study (2023). Hearing and vision limitations can alter access to test instructions and performance. Accommodations and documentation of test modality are required before interpreting a low score as cognitive decline. Bias review; Test modality.

Note 42

Treatment burden and cognition. Evered et al., international nomenclature recommendations for perioperative neurocognitive disorders (2018); McGinty et al., systematic review of androgen-deprivation therapy and cognition (2014); and Ruxton et al., systematic review of anticholinergic drugs in older adults (2015). Treatment-related effects are variable, and association does not prove incapacity in an individual. Perioperative nomenclature; ADT review; Anticholinergic review.

Note 43

Delirium and reversible contributors. Inouye, Westendorp, and Saczynski, “Delirium in Elderly People” (2014); Oh et al., “Delirium in Older Persons” (2017). Delirium is an acute disorder of attention and cognition often precipitated by medical illness, surgery, medication, pain, sleep disruption, or metabolic disturbance. Causes may be treatable, but recovery is not always immediate or complete. 2014 review; 2017 review.

Note 44

Performance validity. Lippa, “Performance Validity Testing in Neuropsychology” (2018), and the American Academy of Clinical Neuropsychology consensus statement (2020). Valid interpretation requires consideration of engagement, performance validity, education, language, culture, neurological status, and the full clinical picture. Clinical review; AACN consensus.

Note 45

PSA biology and test limitations. National Cancer Institute, “Prostate-Specific Antigen (PSA) Test,” updated January 31, 2025; and NCI, “Prostate Cancer Screening (PDQ®),” updated April 8, 2025. PSA is produced by normal and malignant prostate cells. Elevated results can arise without cancer, and cancer can be present despite a non-elevated result. False positives, biopsy, overdiagnosis, and overtreatment are central harms. NCI PSA fact sheet; NCI screening PDQ.

Note 46

USPSTF screening recommendations. U.S. Preventive Services Task Force, “Prostate Cancer: Screening,” May 8, 2018. The USPSTF recommends individualized decision-making for men ages fifty-five through sixty-nine and recommends against routine PSA-based screening for men seventy and older. The recommendation applies to population screening and does not resolve the book’s proposed occupational policy for presidents. USPSTF.

Note 47

AUA/SUO risk-adapted screening. American Urological Association/Society of Urologic Oncology, “Early Detection of Prostate Cancer Guideline,” 2023, amended 2026. PSA is the primary screening modality. Shared decision-making, prior PSA, age, risk, health, and life expectancy inform intervals and discontinuation. The guideline does not require annual PSA testing for every older man. AUA/SUO 2026 guideline.

Note 48

Biden diagnosis and last known PSA. See note 6 for the public diagnosis and PSA-history source set. AP and Reuters reported the office’s statements; those facts do not establish biological onset, earlier detectability, prior knowledge, or concealment.

Note 49

Biden treatment update. Associated Press and Reuters, October 11, 2025. A spokesperson said Biden was receiving radiation therapy and hormone treatment. Public reporting did not disclose the complete regimen, radiation target, PSA response, imaging response, or treatment-related functional effects. AP; Reuters.

Note 50

Gleason grade, metastatic disease, and retrospective timing. Reuters, “Biden’s Aggressive Prostate Cancer: What You Need to Know,” May 19, 2025; and NCI prostate-cancer treatment resources. A Gleason score of 9 indicates high-grade disease, and bone metastasis establishes advanced cancer. Neither finding determines the date malignant cells first arose, when PSA became abnormal, when diagnosis became clinically possible, or when any person knew. Reuters; NCI treatment PDQ.

Note 51

Advanced prostate-cancer treatment and monitoring. NCI, “Hormone Therapy for Prostate Cancer”; NCI, “Prostate Cancer Treatment (PDQ®)”; and AUA/SUO, “Advanced Prostate Cancer Guideline,” amended 2026. Metastatic hormone-sensitive disease is treated with systemic androgen suppression and case-specific intensification. PSA is useful for monitoring but cannot be interpreted alone, particularly because androgen suppression affects PSA expression. NCI hormone therapy; NCI treatment PDQ; AUA advanced guideline.

Note 52

ADT physical and metabolic effects. NCI, “Hormone Therapy for Prostate Cancer.” Documented potential effects include hot flashes, sexual dysfunction, bone-density loss, fractures, loss of muscle mass and strength, weight gain, insulin resistance, lipid changes, mood changes, and fatigue. Frequency and severity vary by regimen, duration, age, and comorbidity. NCI.

Note 53

ADT and cognition. NCI, “Cognitive Impairment in Adults With Cancer (PDQ®)”; McGinty et al., systematic review and meta-analysis (2014); and Gonzalez et al., controlled longitudinal study (2015). Some studies identify group-level cognitive differences in men receiving ADT, but results vary by test, baseline method, domain, and study design. ADT exposure does not establish cognitive impairment in an individual. NCI PDQ; McGinty review; Gonzalez study.

Note 54

Cancer fatigue, radiation, and bone metastasis. NCI, “Fatigue and Cancer”; NCI, “Fatigue (PDQ®)”; and Reuters’ May 2025 disease summary. Cancer, radiation, systemic treatment, pain, anemia, sleep disruption, and emotional distress may contribute to fatigue. Bone metastases may be asymptomatic or cause pain, fracture, mobility limitation, or spinal-cord compression. These complications should not be presumed in Biden without specific evidence. NCI patient fatigue; NCI professional PDQ; Reuters.

Note 55

Presidential privacy, physician duties, and lawful disclosure. AMA Journal of Ethics, “Health and Mental Competency of Presidents” (2000); The Hastings Center, “Clinical Ethics and a President’s Capacity” (2024); and HHS, “Summary of the HIPAA Privacy Rule.” These sources recognize tension between presidential privacy and public interest. HIPAA permits disclosure with authorization and in defined circumstances required or permitted by law; it does not itself create a public-disclosure mandate. AMA Journal of Ethics; Hastings Center; HHS.

Note 56

Biden’s reelection announcement. “Biden Touts Accomplishments and Vision as He Officially Launches Reelection Campaign,” PBS NewsHour, April 25, 2023; and Biden campaign announcement video. Biden framed the campaign around preserving democracy and finishing the administration’s work. These sources establish the public decision and rationale, not the private medical information available to advisers. PBS NewsHour.

Note 57

DNC rules and the absence of a medical-vetting requirement. Democratic National Committee delegate-selection and convention materials, including the 2024 permanent rules and official nominating-process releases. The reviewed rules govern delegates, petitions, convention procedure, and nomination. They do not establish a mandatory medical or cognitive certification for presidential candidates. This is an interpretation of the published rules, not proof that no individual party official ever discussed health privately. DNC permanent-rules release.

Note 58

The planned virtual roll call. Associated Press, “Democrats to Nominate Biden by Virtual Roll Call to Meet Ohio Ballot Deadline,” May 28, 2024; DNC Rules Committee releases, July 24–August 6, 2024. The procedure was announced before the June debate in response to Ohio’s certification deadline. Biden withdrew before the presidential roll call; the later virtual process nominated Kamala Harris. AP; DNC.

Note 59

Post-debate Democratic pressure and withdrawal. Associated Press, July 18–21, 2024; Reuters, July 11 and July 22, 2024; and Biden’s July 21 withdrawal letter. Reporting documented public calls to withdraw, private concern from senior Democrats, worsening polling, and Biden’s decision to end the campaign. These sources do not establish a medical diagnosis or prove that all party leaders possessed the same private information. AP—pressure; AP—withdrawal; Reuters.

Note 60

Democratic voter opinion after the debate. Associated Press-NORC Center for Public Affairs Research, July 17, 2024. Nearly two-thirds of Democrats in the poll said Biden should withdraw. Poll results measure opinion at the time; they are not evidence of medical impairment. AP-NORC.

Note 61

Media availability. See note 1 for the Axios/Kumar data. The evidence supports fewer formal press conferences and interviews alongside numerous short informal exchanges; reduced access limits observation but does not prove impairment.

Note 62

Reported access and staff management. Wall Street Journal, “Behind Closed Doors, Biden Shows Signs of Slipping,” June 4, 2024, and “How the White House Functioned With a Diminished Biden,” December 19, 2024; Jake Tapper and Alex Thompson, Original Sin (2025). These sources report restricted access, shorter or more controlled meetings, and staff intermediation. The White House and former aides disputed central characterizations. Person-specific claims must remain attributed. WSJ—June 2024; WSJ—December 2024.

Note 63

Press access and the 2024 debate. White House Correspondents’ Association, statement of June 27, 2024; Reuters, June 27, 2024. The WHCA objected when CNN declined to place the White House travel pool inside the studio for the entire debate, arguing that direct observation provides context beyond the television production. The dispute concerned independent access, not proof of a medical condition. WHCA; Reuters.

Note 64

White House and campaign pressure on coverage. Associated Press, “It’s an Election Year, and Biden’s Team Is Signaling a More Aggressive Posture Toward the Press,” February 21, 2024. The article documented official objections to coverage of the Hur report and Biden’s age and a WHCA response concerning use of internal press channels. Criticism of coverage is not itself censorship, but it is relevant to the access and accountability environment. AP.

Note 65

Medical calls for cognitive evaluation. Sanjay Gupta, CNN analysis and transcript, July 5–11, 2024; Jeffrey Kuhlman interview reported by The Washington Post, June 7, 2025. Gupta called for detailed evaluation after the debate. Kuhlman’s criticism of the 2024 examination was made publicly in 2025, after Biden left office. Neither physician diagnosed Biden from public evidence. CNN transcript; Washington Post.

Note 66

The Goldwater Rule. American Psychiatric Association, “APA Reaffirms Support for Goldwater Rule,” March 16, 2017; APA Ethics Committee opinions updated through 2025. The rule governs APA member psychiatrists and bars a professional opinion about a public figure’s mental state without examination and authorization, while permitting general psychiatric education. Its broader caution is instructive but does not formally bind all physicians or journalists. APA; APA ethics opinions.

Note 67

Journalism ethics. Society of Professional Journalists, “SPJ Code of Ethics.” The code urges journalists to seek truth, minimize harm, act independently, and be accountable and transparent. It advises consideration of source motives, restraint in granting anonymity, explanation of anonymity, opportunity to respond, and prompt correction. The code is a professional framework rather than enforceable law. SPJ.

Note 68

Media postmortems and the cover-up claim. Columbia Journalism Review, “Unpleasant Stuff,” July 16, 2024; Jon Allsop, “Who’s to Blame for Missing Biden’s Decline?” The New Yorker, May 23, 2025. These analyses describe the difficulties of age reporting and challenge simplistic accounts of either complete press ignorance or a coordinated media cover-up. They are media criticism, not clinical evidence. CJR; The New Yorker.

Note 69

The compressed Harris campaign and election result. DNC releases on Harris’s August 2024 nomination; Associated Press post-election reporting. Harris consolidated delegates and built a campaign after Biden’s July withdrawal, but Donald Trump won the 2024 election. Claims that the timing caused the result remain political interpretation because many variables affected the election. DNC certification; AP post-election analysis.

Note 70

Twenty-Fifth Amendment text and overview. U.S. Constitution, Amendment XXV; Constitution Annotated, “Overview of Twenty-Fifth Amendment.” The amendment was proposed in 1965 and ratified in 1967. The text does not define inability or require clinical testing. Amendment text; Overview.

Note 71

Pre-amendment presidential inability. Constitution Annotated, “Presidential Inability Before the Twenty-Fifth Amendment’s Ratification.” Garfield’s prolonged incapacity and Wilson’s 1919 stroke exposed uncertainty over temporary exercise of presidential power. The source does not prove every later claim about Wilson’s cognition or Edith Wilson’s decision-making. Constitution Annotated.

Note 72

Section 3 implementation. Constitution Annotated, “Implementation of the Twenty-Fifth Amendment,” and presidential transfer letters. Reagan, George W. Bush, and Biden transferred authority during medical procedures; Biden’s 2021 transfer lasted approximately eighty-five minutes. Constitution Annotated; Biden letter; Acting-president list.

Note 73

Section 4 mechanics. U.S. Constitution, Amendment XXV, Section 4. The vice president and required majority may declare inability; a presidential challenge triggers the four-day response process and possible congressional decision. Congress must assemble within forty-eight hours if necessary, and two-thirds of both Houses is required for the vice president to continue as Acting President. Section 4 has never been invoked. Constitution Annotated.

Note 74

The Section 4 “other body.” Constitution Annotated, “Presidential Inability and the 89th Congress: Floor Debates.” Congress may create another body, but the vice president remains indispensable. The framing history indicates that at least some sponsors understood the other body as replacing the Cabinet for this function. Congress has never created it. Constitution Annotated.

Note 75

Principal officers under Section 4. U.S. Department of Justice, Office of Legal Counsel, “Operation of the Twenty-Fifth Amendment Respecting Presidential Succession,” June 14, 1985. OLC concluded that the principal officers are the heads of departments listed in 5 U.S.C. § 101. The manuscript therefore avoids hard-coding a fixed Cabinet number. DOJ OLC.

Note 76

Appointments Clause limits. Constitution Annotated, “Overview of Appointments Clause” and “Officer and Non-Officer Appointments.” Persons exercising significant federal authority are Officers of the United States and must be appointed through constitutionally permitted methods. Investigative or advisory functions may be treated differently from binding executive power. Appointments overview; Officer analysis.

Note 77

Congressional control restrictions. Constitution Annotated, “Restrictions on Congress’s Authority.” Congress may not retain appointment or removal control inconsistent with separation of powers. The validity of fixed terms and removal-for-cause protection depends on the board’s powers and location. Constitution Annotated.

Note 78

Congressional oversight of the White House. Department of Justice, Office of Legal Counsel, “Congressional Oversight of the White House,” January 8, 2021. OLC states that White House oversight presents greater constitutional constraints than ordinary agency oversight. The opinion reflects the Executive Branch position and is not a Supreme Court holding. DOJ OLC.

Note 79

HIPAA scope. U.S. Department of Health and Human Services, “Covered Entities and Business Associates” and “Summary of the HIPAA Privacy Rule.” HIPAA applies to specified regulated entities, not automatically to every federal body possessing medical information. Covered entities; Privacy Rule.

Note 80

Privacy Act. U.S. Department of Justice, Office of Privacy and Civil Liberties, “Privacy Act of 1974” and “Disclosures to Third Parties.” A federal agency system of records may be subject to consent, access, amendment, and disclosure rules. Applicability depends on the board’s structure and record system. Privacy Act; Disclosure overview.

Note 81

Federal Advisory Committee Act. General Services Administration, “Federal Advisory Committee Act Management Overview” and “When Is FACA Applicable?” Advisory committees generally face public-notice, open-meeting, and records requirements, subject to lawful closure. A medical board may require express statutory treatment. GSA overview; Applicability.

Note 82

Temporary disability and delegation. U.S. Department of Justice, Office of Legal Counsel, “Presidential Succession and Delegation in Case of Disability,” April 3, 1981. The memorandum addresses acting-presidential authority and the difference between constitutional transfer and ordinary delegation. DOJ OLC.

Note 83

Presidential qualifications and ballot access. Constitution Annotated, “Qualifications for the Presidency,” “Election Laws,” and “Ballot Access.” Article II identifies citizenship, age, and residency qualifications. State ballot rules and party associational rights operate under separate constitutional constraints. A medical-certification proposal should not be described as an automatically valid new constitutional qualification. Presidential qualifications; Election laws; Ballot access.

Note 84

National-party nomination rules. Democratic National Committee, 2024 Rules Committee Unity Resolution and permanent-rules materials; Republican National Committee, Rules of the Republican Party and 2024 convention call. These documents demonstrate extensive party authority over delegates, conventions, petitions, binding, and nomination procedures. They do not resolve every proposed medical condition on participation or ballot access. DNC resolution; RNC rules; RNC convention call.

Note 85

Conventions and delegate activity under federal election law. Federal Election Commission, “Raising and Spending Funds for the National Party’s Nominating Convention” and “Candidate—Raising and Spending Funds for Delegate Activity.” The FEC treats conventions and delegate activity as regulated federal election activity. The FEC is not a medical adjudicator. Convention financing; Delegate activity.

Note 86

The 2028 election cycle. Federal Election Commission, “2028 Election—United States President.” The page confirms an active federal campaign-finance cycle. It does not establish one nationwide primary calendar; timing depends on state law and party procedure. FEC.

Note 87

NIST Cybersecurity Framework 2.0. National Institute of Standards and Technology, Cybersecurity Framework 2.0, February 26, 2024. CSF 2.0 organizes risk management around Govern, Identify, Protect, Detect, Respond, and Recover. It is guidance, not a guarantee of security. NIST CSF 2.0.

Note 88

Federal security and privacy controls. NIST SP 800-53 Rev. 5 and SP 800-66 Rev. 2 support risk-based access, audit, privacy, incident, and system controls. Controls require tailoring, implementation, testing, and monitoring. SP 800-53; SP 800-66.

Note 89

Incident response. NIST SP 800-61 Rev. 3, April 2025. Incident response should integrate governance, detection, response, recovery, exercises, and improvement rather than begin after a breach. NIST.

Note 90

Federal advisory committees. See note 81 for the governing GSA/FACA sources. Chapters 9–10 apply that framework to the proposed board and note that express statutory treatment or lawful closure may be required.

Note 91

Evidence-building and evaluation planning. OMB M-21-27 and GAO’s Designing Evaluations support predefined questions, appropriate methods, scientific integrity, measurable objectives, data planning, and learning-oriented revision. OMB; GAO.

Note 92

Federal digital public experience. OMB M-23-22 states that federal digital services should address accessibility, usability, privacy, security, and trust. It supports dashboard design but does not authorize disclosure of protected medical information. OMB.

Note 93

Federal AI governance. OMB M-25-21 emphasizes risk-proportionate governance, privacy, civil rights, and safeguards in federal AI use. It does not justify delegating presidential-capacity determinations to AI. OMB.

Note 94

*Post-presidency reporting in Original Sin. Jake Tapper and Alex Thompson, Original Sin: President Biden’s Decline, Its Cover-Up, and His Disastrous Choice to Run Again* (2025); NPR and PBS interviews with the authors. The book reports allegations based on approximately two hundred interviews, including restricted access, declining function, and management by a protective inner circle. It is a major journalistic source, not a clinical examination, and its person-specific claims remain attributed. Biden’s spokesperson disputed that the reporting proved a cover-up or inability to perform the job. NPR interview; PBS interview; Biden response reported by ABC News.

Note 95

House Oversight majority report and witness record. House Committee on Oversight and Government Reform, majority staff report, The Biden Autopen Presidency: Decline, Delusion, and Deception in the White House, October 28, 2025, and committee witness-video and transcript collection. The Republican majority concluded that senior aides concealed decline, influenced medical messaging, and left unresolved questions about decision-making and autopen use. Those are majority findings and allegations, not judicial findings or a neutral clinical determination. Majority report release; witness record.

Note 96

House Oversight Democratic minority response. Democratic staff of the House Committee on Oversight and Government Reform, memorandum, October 28, 2025. The minority said approximately sixty hours of testimony from fourteen aides portrayed Biden as engaged and capable and contradicted the majority’s cover-up and unauthorized-autopen theory. The memorandum is the partisan counter-analysis of much of the same evidentiary record. Minority memorandum.

Note 97

Article III and advisory opinions. Constitution Annotated, “Advisory Opinion Doctrine” and the Article III case-or-controversy discussion. Federal courts generally may not issue advisory opinions outside concrete disputes. A health-review commission should therefore not be constituted as the Supreme Court exercising judicial power. Constitution Annotated.

Note 98

Extrajudicial service by individual judges. Mistretta v. United States, 488 U.S. 361 (1989), discusses historical extrajudicial service by individual federal judges, including commissions, while preserving separation-of-powers limits; In re Pacific Railway Commission, discussed in Interstate Commerce Commission v. Brimson, 154 U.S. 447 (1894), distinguishes nonjudicial commissioner work from duties assigned to a federal court. This history supports only a carefully limited individual role, not medical jurisdiction for the Supreme Court. Mistretta; Brimson.

Note 99

Chief Justice designation and judicial ethics. 50 U.S.C. § 1803 authorizes the Chief Justice to designate district judges for the Foreign Intelligence Surveillance Court. The Supreme Court’s 2023 Code of Conduct permits limited extrajudicial activity subject to impartiality, dignity, political-activity, and prestige constraints. These sources illustrate possible mechanisms and risks; they do not authorize a presidential-health commission. 50 U.S.C. § 1803; Supreme Court Code of Conduct.

Note 100

The Twenty-Fifth Amendment’s named actors. Amendment XXV, Section 4, and the congressional floor-debate history establish that any “other body” created by Congress still acts with the vice president, while Congress decides a contested transfer by two-thirds of each chamber. A judicial integrity panel cannot replace that constitutional chain without amendment. Amendment text; floor-debate history.

Note 101

June 2025 executive-branch investigation. White House, “Fact Sheet: President Donald J. Trump Directs Review of Certain Presidential Actions,” June 4, 2025. The memorandum directed investigation of alleged deception concerning Biden’s mental state and potentially unauthorized exercise of presidential authority or autopen use. The directive established an investigation; it did not establish that O’Connor or any other named person committed a crime. White House fact sheet.

Note 102

Reported 2026 status of the autopen investigation. CBS News, March 5, 2026, reported that the D.C. U.S. attorney’s office had closed its autopen probe; other contemporaneous reporting quoted a Justice Department official saying a narrower review of pardons and commutations remained open. The public reporting was therefore inconsistent about scope and status. No public indictment of Kevin O’Connor was identified in the sources reviewed through August 9, 2026. CBS News.

Note 103

The Fifth Amendment in congressional investigations. Constitution Annotated, “Constitutional Limits of Congress’s Investigation and Oversight Powers.” A properly invoked privilege protects a congressional witness from compelled statements that may furnish evidence for a criminal prosecution. A patient’s medical authorization does not waive a physician-witness’s personal constitutional privilege. Constitution Annotated.

Note 104

Use and derivative-use immunity. 18 U.S.C. §§ 6002 and 6005 authorize compelled congressional testimony after specified procedures. The compelled testimony and information derived from it may not be used against the witness in a criminal case, except for perjury, false statements, or noncompliance. A committee request generally requires approval by two-thirds of the full committee and notice to the attorney general. 18 U.S.C. § 6002; 18 U.S.C. § 6005.

Note 105

Constitutional sufficiency of use immunity. Kastigar v. United States, 406 U.S. 441 (1972), held that use and derivative-use immunity is coextensive with the Fifth Amendment privilege and can support compelled testimony. In a later prosecution, the government bears the burden of proving an independent source for its evidence. Kastigar.

Note 106

Fauci’s July 2026 testimony. Senate Committee on Homeland Security and Governmental Affairs, “Testimony of Anthony Fauci,” July 29, 2026. The official hearing page establishes the date, forum, and witness role. Fauci invoked the Fifth Amendment repeatedly during the hearing. Official hearing page.

Note 107

Fauci pardon and disputed privilege. Associated Press, August 5, 2026. Biden’s pardon covered specified federal conduct from 2014 through January 19, 2025. Committee Republicans argued that it removed federal criminal exposure for covered conduct; Fauci’s side cited possible state exposure, new-statement liability, threats of prosecution, and administration challenges to the pardons. The validity and scope of the privilege were contested, not resolved by the hearing itself. Associated Press legal analysis.

Note 108

Fauci contempt referral. Associated Press, August 6, 2026. The Senate Homeland Security and Governmental Affairs Committee voted along party lines to hold Fauci in contempt and refer the matter to the Justice Department. The referral did not itself adjudicate the privilege or compel prosecution. Associated Press.

Note 109

Media-review principles. See notes 22–28 and 61–69 for the presidential-health history, access record, Goldwater Rule, journalism ethics, and media postmortems. Chapter 11’s access ledger, evidence ladder, two-direction audit, and mandatory postmortem are the author’s policy proposals rather than existing newsroom mandates.

Note 110

Judicial commission legal boundary. See notes 74 and 97–100. Article III’s case-or-controversy requirement, the history of extrajudicial service by individual judges, the Supreme Court Code of Conduct, and the Twenty-Fifth Amendment’s named actors create important limits. The sitting-Justice and retired-judge alternatives both require constitutional counsel and legislation; neither is current law.

Note 111

Roosevelt’s cardiovascular decline. National Park Service, Home of Franklin D. Roosevelt National Historic Site, “The Dying President.” The chronology describes the March 1944 specialist examination, cardiomegaly, congestive heart failure, murmur, severe hypertension, exertional dyspnea, treatment, later deterioration, and the secrecy surrounding the diagnosis. It also presents conflicting contemporary assessments of Roosevelt’s performance at Yalta. National Park Service.

Note 112

The historical debate over Roosevelt at Yalta. Franklin D. Roosevelt Presidential Library and Museum, “FDR at Yalta: Confront the Issue.” The educational source acknowledges severe illness and limited endurance while rejecting claims that mental impairment determined Roosevelt’s diplomacy. It documents the competing goals, military constraints, Poland dispute, Soviet position, and subsequent historical controversy. FDR Presidential Library.

Note 113

Cold War origins and the limits of monocausal claims. National Park Service, “Zones of Contention.” The overview describes Yalta, Potsdam, Poland, Germany, Soviet control in Eastern Europe, and the developing disputes among former allies. It supports treating the Cold War as a sequence of geopolitical conflicts rather than attributing it to one leader’s illness. National Park Service.

Note 114

Reagan’s 1981 gunshot and surgery. Ronald Reagan Presidential Library, “Assassination Attempt on Reagan.” The official account states that Reagan was shot on March 30, 1981, taken to George Washington University Hospital, and underwent surgery to remove a bullet from his left lung. Reagan Presidential Library.

Note 115

Continuity discussions and hospital operations. Ronald Reagan Presidential Library, Richard V. Allen Papers scope note, contemporaneous White House briefing transcript, and 1981 Public Papers of the President, Appendix A. The Allen collection states that the Situation Room monitored Reagan’s condition, the vice president’s whereabouts, and whether to invoke the Twenty-Fifth Amendment. The White House briefing states that the Cabinet was gathered in case it was needed for Twenty-Fifth Amendment action. The official diary records Reagan receiving a briefing in his hospital room on April 1 and Vice President Bush presiding over an NSC meeting on Reagan’s behalf. Allen Papers; White House briefing transcript; 1981 Public Papers, Appendix A.

Note 116

Temporary presidential inability. Twenty-Fifth Amendment, Section 3, and Congressional Research Service, The Twenty-Fifth Amendment: Sections 3 and 4—Presidential Disability. Section 3 provides for a temporary written transfer and resumption of authority. CRS identifies sudden injury, illness, and general anesthesia as possible applications and reviews later uses, including Reagan’s 1985 transfer. Constitution Annotated; Congressional Research Service.

Note 117

Fatigue as a disputed factor at Yalta. The Department of State’s Office of the Historian describes the military, territorial, and diplomatic constraints at Yalta and notes both later criticism and substantial Soviet concessions. A History News Network essay presents the narrower retrospective argument that Roosevelt’s exhaustion may have affected particular late-conference bargaining. The second source is an interpretation in a continuing historical dispute, not a clinical finding. Office of the Historian; History News Network.

Note 118

Term limits after Roosevelt. Constitution Annotated explains that the Twenty-Second Amendment was adopted largely in response to Roosevelt’s third and fourth terms and was ratified in 1951. The amendment limits election to the presidency; it does not create an annual medical-capacity review. Constitution Annotated; Twenty-Second Amendment.

Note 119

Biden’s announced diagnosis and PSA statement. Associated Press, May 18 and May 20, 2025. Biden’s office announced Gleason 9 prostate cancer metastatic to bone after urinary symptoms and a prostate nodule. It later said his “last known” PSA was in 2014 and that he had not previously been diagnosed. The 2014 result and a longitudinal PSA record were not disclosed in the statement. Diagnosis; PSA statement.

Note 120

Post-diagnosis radiation and hormone treatment. Associated Press, October 11 and October 20, 2025. A spokesperson said Biden was receiving radiation and hormone treatment and later announced completion of a radiation course. The public reports did not identify the complete hormonal regimen or establish that treatment began while Biden was president. Treatment announcement; Radiation completion.

Note 121

What grade, stage, and PSA can establish. National Cancer Institute, prostate-cancer treatment and PSA resources. Gleason grading describes microscopic aggressiveness; staging describes extent of disease; PSA can support screening, diagnostic evaluation, and monitoring. None supplies an exact biological onset date or proves when a patient or physician first knew of the disease. Prostate cancer treatment; PSA fact sheet.

Note 122

Older-patient PSA decisions. American Urological Association/Society of Urologic Oncology, Early Detection of Prostate Cancer: AUA/SUO Guideline (2023). The guideline emphasizes shared decision-making and individualized screening in older patients; it discusses discontinuing or lengthening screening for some patients age seventy-five or older with PSA below 3 ng/mL. It does not establish a presidential occupational standard, which is the author’s policy proposal. AUA/SUO guideline.

Note 123

Androgen-deprivation treatment effects. National Cancer Institute, “Hormone Therapy for Prostate Cancer.” The fact sheet describes common effects including fatigue, muscle and bone loss, reduced strength, weight and metabolic change, hot flashes, and mood effects. Individual experience varies; a side-effect profile cannot establish that a specific person experienced a particular cognitive or physical limitation. National Cancer Institute.

Note 124

Whole-body CT screening. Food and Drug Administration, “Full-Body CT Scans—What You Need to Know.” FDA states that evidence has not shown more benefit than harm for whole-body CT screening of asymptomatic people and identifies incidental findings, additional testing, false reassurance, and radiation exposure as concerns. FDA.

Note 125

Health data and foreign leverage. National Counterintelligence and Security Center, National Counterintelligence Strategy (2024) and “Protecting Personal Health Data from Foreign Exploitation” (2022). The sources warn that hostile intelligence services can use vulnerabilities derived from health and other personal data for targeting, coercion, manipulation, or blackmail. They support a general security-risk analysis, not a person-specific allegation concerning Biden. Counterintelligence strategy; Health-data warning.

Note 126

Clooney’s public warning and the later recognition allegation. Axios, July 10, 2024, reported George Clooney’s public call for Biden to leave the race after seeing him at a June fundraiser. Axios, May 13, 2025, summarized the later Original Sin allegation that Biden did not initially recognize Clooney at that event. The recognition claim is attributed post-presidency reporting, not a medical diagnosis or a statement included in Clooney’s original essay. Contemporaneous public warning; Later book account.

Note 127

The 2024 replacement nomination process. Democratic National Committee releases, July 30 and August 6, 2024. Harris was the only candidate to qualify for the virtual-roll-call ballot; the party reported support from 99 percent of participating delegates and later certified Harris and Tim Walz. The process was a delegate nomination under party rules, not a new state voter primary. Roll-call process; Certification.

Note 128

Autopen and decision authentication. Department of Justice, Office of Legal Counsel, “Whether the President May Sign a Bill by Directing That His Signature Be Affixed to It,” July 7, 2005. The opinion concludes that a president who has approved and decided to sign a bill may direct a subordinate to affix the signature, including by autopen; it does not permit delegation of the underlying presidential decision. See also notes 95–96 for the competing 2025 House committee interpretations of Biden-era authorization. DOJ Office of Legal Counsel.

Note 129

Presidential MRI, executive physicals, and tumor-marker limits. The Food and Drug Administration states that MRI does not use ionizing radiation and can image nearly any part of the body, while identifying magnetic-field, implant, heating, noise, claustrophobia, and contrast-related safety considerations. The American College of Radiology states that evidence is insufficient to recommend total-body MRI screening for asymptomatic people without risk factors and warns about nonspecific findings and unnecessary follow-up. Cleveland Clinic’s Executive Health program lists total-body MRI or CT among additional scans that may be offered, while Mayo Clinic describes individualized executive examinations based on age, sex, risk, and preventive guidance. The National Cancer Institute explains that most circulating tumor markers lack sufficient sensitivity or specificity for general asymptomatic screening and that false-positive and false-negative results require confirmatory pathways. These sources establish the technical distinction, feasibility, and limitations; the mandatory presidential occupational protocol proposed in this chapter is the author’s policy recommendation, not a current professional guideline. FDA MRI benefits and risks; American College of Radiology; Cleveland Clinic Executive Health; Mayo Clinic Executive Health; NCI tumor markers; NCI screening tests.

Note 130

The 2025 campaign-book record. Jonathan Allen and Amie Parnes, Fight: Inside the Wildest Battle for the White House (William Morrow, April 2025); Chris Whipple, Uncharted: How Trump Beat Biden, Harris, and the Odds in the Wildest Campaign in History (Harper Influence, April 2025); Jake Tapper and Alex Thompson, Original Sin: President Biden’s Decline, Its Cover-Up, and His Disastrous Choice to Run Again (Penguin Press, May 2025); and Josh Dawsey, Tyler Pager, and Isaac Arnsdorf, 2024: How Trump Retook the White House and the Democrats Lost America (Penguin Press, July 2025). These books are journalistic reconstructions, not medical records. Their claims are attributed in the text and weighed by sourcing, timing, corroboration, and contrary evidence. Original Sin—official publisher; 2024—official publisher; Fight reporting; Uncharted excerpt reporting.

Note 131

*Scope and limits of Original Sin.* The publisher identifies a May 20, 2025 publication date and describes reporting on efforts to hide decline. Tapper and Thompson stated in interviews that they conducted more than two hundred interviews, largely with Democrats; many key sources remained anonymous and most interviews occurred after the election. The reporting supports a substantial pattern allegation, not a clinical diagnosis or judicial finding. Publisher; PBS NewsHour interview; NPR interview; TIME interview.

Note 132

Cognitive-test discussion and campaign access. 2024 is described by its publisher as drawing on extraordinary access to the Trump, Biden, and Harris teams; Axios reported that the authors conducted more than three hundred interviews. Reporting on the book stated that aides considered a cognitive examination in early 2024 but decided the political optics could worsen age concerns even if Biden passed. The book report establishes an attributed internal discussion, not the content of a medical recommendation. Official publisher; Axios; contemporaneous summary.

Note 133

Harris, Jean-Pierre, and competing insider interpretations. Kamala Harris, 107 Days (Simon & Schuster, September 2025), called deference to Joe and Jill Biden on the reelection decision “recklessness” while defending his substantive judgment and distinguishing presidential performance from campaign fatigue. Karine Jean-Pierre, Independent (Legacy Lit, October 2025), defended Biden and criticized the party’s response. These are named insider accounts with different loyalties and interpretations. Harris—official publisher; Associated Press on Harris excerpt; Jean-Pierre—official publisher.

Note 134

Competing House committee conclusions. House Committee on Oversight and Government Reform, Republican majority report, The Biden Autopen Presidency: Decline, Delusion, and Deception in the White House (October 28, 2025); and Democratic committee staff memorandum responding to the investigation (October 28, 2025). The majority alleged concealment and unauthorized-action risk. The minority said witnesses consistently described Biden as capable and did not corroborate unauthorized autopen acts. The Associated Press reported that the majority report offered no concrete evidence that aides enacted policies without Biden’s knowledge. These are competing partisan analyses of testimony, not neutral medical or judicial findings. Majority report; minority memorandum; Associated Press.

Note 135

Former-aide testimony. House interview and deposition transcripts include Ron Klain, Jeff Zients, Mike Donilon, Anita Dunn, and other senior officials. The testimony contains both reassurance and acknowledgment of age, fatigue, physical accommodations, reduced schedule burden, or changed recall and communication. The book treats direct testimony as stronger than anonymous summary but distinguishes witness observation from standardized clinical evaluation. Ron Klain transcript; committee report and transcript index.

Note 136

O’Connor deposition and privilege. See notes 9 and 101–105. O’Connor’s transcript shows broad assertions of medical confidentiality and the Fifth Amendment. Counsel cited potential federal criminal exposure in the context of an executive-branch investigation and expressly stated that invocation was not an admission. The transcript does not prove false certification, a concealed diagnosis, or incapacity. It does demonstrate why a public certification should be independently auditable. Official transcript; Fifth Amendment overview; congressional immunity statutes.

Note 137

Hur report and released audio. Special Counsel Robert Hur declined to charge Biden and discussed memory in the context of proving willfulness and anticipated jury perception. The report did not make a medical diagnosis or a judicial finding of incompetence. Audio released in 2025 showed pauses and recall difficulty as well as substantive recollection. DOJ report; Axios audio and transcript presentation; Associated Press.

Note 138

Ghostwriter recordings released in 2026. After Biden ended litigation challenging disclosure, approximately three hours of audio and 117 pages of redacted transcripts from 2016–2017 interviews with ghostwriter Mark Zwonitzer were released by the Oversight Project, an arm of the Heritage Foundation. Associated Press reporting identified both memory lapses and detailed recall and noted separate classified-information issues. The recordings predate Biden’s presidency and do not establish his later functional state. Litigation withdrawal; release and content.

Note 139

Trump investigation, cancer remarks, and contrary observation. Trump’s June 4, 2025 fact sheet ordered review of alleged concealment and unauthorized presidential action; the order initiated an investigation rather than proving the allegations. Trump’s May 2025 cancer comments confused Gleason grade with stage. On June 4, 2026, Trump said he had not detected cognitive decline during the nearly two-hour November 2024 transition meeting and repeatedly described Biden as “fine.” White House fact sheet; May 2025 remarks; June 2026 transcript.

Note 140

Press postmortem. At the April 2025 White House Correspondents’ Association dinner, Axios reporter Alex Thompson said that the press corps, himself included, had missed much of the story and connected the failure to declining trust. The statement supports institutional self-criticism; it is not evidence that every journalist knowingly concealed impairment. Associated Press; PBS NewsHour interview.

Note 141

Jill Biden’s 2026 memoir and symptom account. Jill Biden, View from the East Wing (Simon & Schuster, June 2026), described fear that Biden was having a stroke during the debate, later acknowledged that he was slowing while denying cognitive decline, and wrote that repeated nighttime urination during the final White House year led her to alert doctors and urge a urology visit. She also described post-diagnosis radiation and hormone pills associated with fatigue and mood changes. Her account is named evidence of symptoms and her perceptions, not a medical chart or proof of in-office cancer knowledge. Associated Press memoir summary; CBS News interview; official publisher.

Note 142

August 2026 cancer update. Hunter Biden told the BBC that his father’s cancer had spread further, was painful, and was debilitating in many respects, while also describing him as continuing public engagement. This family statement concerns the post-presidential disease course and cannot establish when the disease was diagnosed or treated during office. Associated Press.

Note 143

Biden’s forthcoming memoir. Little, Brown announced that Joe Biden’s Promise Me, America is scheduled for November 17, 2026 and is expected to address the reelection and withdrawal decisions. The book had not been published by this edition’s August 9, 2026 research cutoff and is not treated as evidence. Associated Press.

Note 144

Research cutoff and open record. This edition incorporates public material identified through August 9, 2026. The record remains open: litigation, congressional releases, medical disclosures, witness interviews, and future memoirs may add or contradict evidence. Later material should be inserted according to the same hierarchy—authenticated records first, then sworn testimony, named contemporaneous accounts, named retrospective accounts, confidential-source reporting, political allegation, and medical inference.

Note 145

Executive-health benefits and insurance underwriting. Mayo Clinic states that more than 1,400 companies offer its Executive Health Program as a leadership benefit and describes recurring, individualized evaluations using a standard protocol plus physician-ordered and optional services. Cleveland Clinic describes corporate executive examinations and identifies total-body MRI as an additional scan that may be arranged; it also states that substantial portions of executive-health services may not be covered by insurance. MassMutual says traditional life underwriting typically involves a physical examination and laboratory testing, while some algorithmic pathways omit them. Guardian identifies blood, urine, vital signs, and possible ECG, x-ray, stress, or cognitive testing. Mutual of Omaha materials describe recent annual or executive physicals and laboratory/cardiac requirements for some high-value underwriting pathways. Principal advertises some executive and key-person products with no medical requirements. Together these sources support the proposition that corporations and insurers use medical verification and executive-health benefits to manage concentrated leadership risk. They do not establish that executive insurers generally require whole-body MRI. The mandatory presidential MRI protocol remains the author’s proposed occupational standard. Mayo Clinic Executive Health; Mayo Clinic program FAQ; Cleveland Clinic Executive Health; Cleveland Clinic exam and insurance information; MassMutual underwriting practices; Guardian underwriting; Mutual of Omaha underwriting checklist; Principal key-person insurance.

Note 146

Neely Tucker, Library of Congress, “Garfield Shooting: July 2, 1881, and the Medical Disaster That Ensued,” July 1, 2019. Source. Institutional archival account; public bulletins and disclosure context, not a private clinical chart.

Note 147

Theodore N. Pappas, “Bright’s Disease, Malaria, and Machine Politics,” 2017. DOI: 10.1055/s-0037-1612632. Source. Historical medical research tracing contemporary reporting; exact renal etiology remains unresolved.

Note 148

College of Physicians of Philadelphia, “William W. Keen’s material related to the operation of President Cleveland,” archival finding aid, hosted by Penn. Source. Collection description establishes correspondence provenance and the 1893/1917 chronology; individual letters are not reproduced here.

Note 149

Theodore Roosevelt, An Autobiography, Macmillan, 1913, printed p. 48; Library of Congress digital image 68. Source. Primary autobiographical account of persistent left-eye visual impairment; not a contemporaneous ophthalmology examination.

Note 150

Robin von Seldeneck, Woodrow Wilson Presidential Library, “That Veto,” October 31, 2019. Source. Institutional interpretation with links to physician reports and correspondence; retained function and filtered information both matter.

Note 151

Theodore N. Pappas, “President Warren G. Harding and the 5 Doctors Who Managed His Final Illness,” Annals of Surgery Open 1(2):e006, 2020. DOI: 10.1097/AS9.0000000000000006. Source. Records-based retrospective medical analysis; no autopsy confirmed the terminal mechanism. Publication year is 2020, not the later PMC deposit year.

Note 152

Franklin D. Roosevelt Presidential Library, FDR’s Health: Confront the Issue, documentary exhibit, 2014. Source. Clinical and scheduling documents with collection locators; prescribed routine is not proof of daily adherence.

Note 153

Howard G. Bruenn, “Clinical Notes on the Illness and Death of President Franklin D. Roosevelt,” Annals of Internal Medicine 72(4):579–591, April 1970. DOI: 10.7326/0003-4819-72-4-579. Source. Original physician account; bibliographic record and excerpts reproduced in the FDR Library exhibit.

Note 154

Samuel W. Rushay Jr., National Archives, “The President Is Very Acutely Ill,” Prologue, Fall 2012. Source. Archival comparison of Graham’s report and press briefings; retained presidential work prevents inference of established incapacity.

Note 155

Dwight D. Eisenhower Presidential Library, Presidential Years, presidential chronology. Source. Institutional chronology; known major illness is not classified as wholly concealed.

Note 156

National Archives, “An Ailing Ike: How Eisenhower’s Health Affected His Role in the 1960 Election,” Prologue, Fall 2012. Source. Physician diary and correspondence; describes a rhythm episode and private workload concerns, not a proven cognitive diagnosis or first-disclosure date.

Note 157

Robert Dallek, “The Medical Ordeals of JFK,” The Atlantic, December 2002. Source. Historian’s direct report of newly accessed medical records; medical burden does not establish the cause of individual policy decisions.

Note 158

Reagan’s personal physicians, statement on Alzheimer’s diagnosis, November 5, 1994; Ronald Reagan Presidential Library. Source. Primary public diagnostic statement; does not establish dementia during the presidency.

Note 159

Ronald Reagan, letter on discharge of presidential powers during surgery, July 13, 1985, and official note; Ronald Reagan Presidential Library. Source. Primary letter documents transfer; preserve its expressed constitutional reservations.

Note 160

American College of Radiology, Statement on Screening Total Body MRI, April 17, 2023. Source. Evidence insufficient for routine total-body screening of asymptomatic people without relevant risk factors; distinguish a proposed occupational policy.

Note 161

U.S. Preventive Services Task Force, Prostate Cancer: Screening, final recommendation, May 8, 2018. Source. Recommendation concerns asymptomatic adults without a prior prostate-cancer diagnosis; screening is distinct from symptom evaluation and known-cancer monitoring.

Note 162

James E. Guba and Philander D. Chase, “Anthrax and the President, 1789,” Washington Papers, originally Spring 2002; web republication June 12, 2015. Editorial reconstruction reproducing presidential correspondence and contemporary press references. Historical terminology is not a confirmed modern pathogen. Source.

Note 163

George Washington to David Stuart, June 15, 1790, Founders Online, National Archives. Primary correspondence describing residual symptoms; not a microbiological diagnosis. Source.

Note 164

Ludwig M. Deppisch and colleagues, “Andrew Jackson’s Exposure to Mercury and Lead: Poisoned President?”, JAMA 282:569–571, August 11, 1999. DOI 10.1001/jama.282.6.569. Original analysis of attributed hair samples from 1815 and 1839; neither sample dates to the presidency. Source.

Note 165

William Henry Harrison’s physicians, report of April 4, 1841, American Presidency Project transcription. Contemporary observations and diagnostic interpretation. Source.

Note 166

Jane McHugh and Philip A. Mackowiak, “Death in the White House,” Clinical Infectious Diseases, 2014. DOI 10.1093/cid/ciu470. Retrospective enteric-infection hypothesis; no recovered culture or definitive pathogen identification. Source.

Note 167

Oak Ridge National Laboratory, “Zachary Taylor’s Deadly Snack,” November 27, 2018, institutional account of the laboratory’s 1991 arsenic analysis. Evidence addresses arsenic, not every possible cause of death. Source.

Note 168

Franklin Pierce, inaugural address, March 4, 1853, American Presidency Project. Primary public acknowledgment of sorrow; not a psychiatric evaluation. Source.

Note 169

Peter Wallner, Booknotes interview with Brian Lamb, November 28, 2004, C-SPAN transcript. Biographer’s attributed interpretation and counterevidence concerning timing and severity of alcohol-related impairment. Source.

Note 170

U.S. House of Representatives, Office of the Historian, historical highlight concerning the National Hotel epidemic and Representative David Robison. Institutional reconstruction of the public 1857 outbreak; the page’s June 24, 1859 date concerns Robison’s death. Source.

Note 171

Armond S. Goldman and Frank C. Schmalstieg Jr., “Abraham Lincoln’s Gettysburg Illness,” Journal of Medical Biography 15(2):104–110, May 2007. DOI 10.1258/j.jmb.2007.06-14. Abstract-supported retrospective smallpox interpretation; full article not independently obtained in this pass. Source.

Note 172

The Lincoln Log, chronology for December 3, 1863, citing the Washington Evening Star report of varioloid. Institutional newspaper citation; original newspaper page not independently retrieved in this pass. Source.

Note 173

Abraham Lincoln to George Opdyke, December 2, 1863, Library of Congress, Abraham Lincoln Papers, item 2838400. Primary letter declining attendance because of illness. Source.

Note 174

Abraham Lincoln, draft proclamation of amnesty and reconstruction, December 8, 1863, Library of Congress, Abraham Lincoln Papers, item 2849300. Primary working document; evidence of activity, not a comprehensive capacity test. Source.

Note 175

Abraham Lincoln to John T. Stuart, January 23, 1841, as reproduced and cited in The Lincoln Log. Personal description of distress before the presidency; not proof of a continuous modern psychiatric diagnosis. Source.

Note 176

Presley M. Rixey, report of William McKinley’s post-shooting medical course, 1901, transcription of the primary report. September 12–13 observations and bulletins compared; original scan not independently inspected in this pass. Source.

Note 177

John G. Sotos, “Taft and Pickwick: Sleep Apnea in the White House,” Chest 124(3):1133–1142, September 2003. DOI 10.1378/chest.124.3.1133. Retrospective interpretation; abstract examined, no contemporary polysomnography. Source.

Note 178

Cary T. Grayson to Joseph P. Tumulty, April 10, 1919, reproduced in Tumulty, Woodrow Wilson as I Know Him, 1921. Primary physician letter within a participant memoir; clinical influenza diagnosis, not viral testing. Source.

Note 179

Sarah Fling, “Spanish Influenza in the President’s Neighborhood,” White House Historical Association, October 2, 2019. Documentary comparison of private physician correspondence and contemporary public reporting. Source.

Note 180

Robert E. Gilbert, “Personal Tragedy and Presidential Performance: Calvin Coolidge as Legislative Leader,” Congress & the Presidency 33(2), 2006. DOI 10.1080/07343460609507674. Retrospective impairment thesis, not a contemporary diagnostic record. Source.

Note 181

Hendrik Booraem V, “Coolidge the Victim?”, Calvin Coolidge Presidential Foundation. Historian’s explicit critique of the impairment thesis; useful disconfirming interpretation, not a clinical examination. Source.

Note 182

Dwight D. Eisenhower Presidential Library, “Eisenhower’s Heart Attack and Presidential Disability,” subject guide. Archival pointers covering the 1955 heart attack, 1956 ileitis, and 1957 stroke; guide is not a substitute for the complete clinical collections. Source.

Note 183

Franz H. Messerli, Kevin R. Loughlin, Adrian W. Messerli, and William R. Welch, “The President and the Pheochromocytoma,” American Journal of Cardiology 99(9):1325–1329, May 1, 2007. DOI 10.1016/j.amjcard.2006.12.043. Pathology-based report; tumor at 1969 autopsy does not establish in-office presence or recognition. Source.

Note 184

R. Yu, A. Pitts, and M. Wei, “Small Pheochromocytomas: Significance, Diagnosis, and Outcome,” Journal of Clinical Hypertension 14(5):307–315, 2012. DOI 10.1111/j.1751-7176.2012.00604.x. Original series with discussion questioning the proposed Eisenhower hypertension connection. Source.

Note 185

Lee R. Mandel, “Endocrine and Autoimmune Aspects of the Health History of John F. Kennedy,” Annals of Internal Medicine 151(5):350–354, September 1, 2009. DOI 10.7326/0003-4819-151-5-200909010-00011. Direct medical-record review; distinguish documented adrenal/thyroid illness from retrospective syndrome interpretation. Source.

Note 186

Lyndon B. Johnson and physicians, presidential news conference, November 3, 1966, American Presidency Project. Primary discussion of incisional hernia, vocal-cord polyp, surgery, and recovery. Source.

Note 187

Leo Janos, “The Last Days of the President,” The Atlantic, July 1973. Participant’s later account of Johnson’s recollection of an actuarial assessment; not the assessment itself or a clinical chart. Source.

Note 188

Marlin Fitzwater, statement on President George H. W. Bush’s health, May 4, 1991, American Presidency Project. Primary public announcement of an abnormal heart rhythm. Source.

Note 189

White House, Digest of Other White House Announcements, entry for May 9, 1991, American Presidency Project. Primary public announcement of Graves’ disease. Source.

Note 190

U.S. Constitution, Twenty-Fifth Amendment, Sections 3–4, National Archives transcription. Existing constitutional transfer procedures; the thirty-day review threshold is the author’s proposal, not a requirement or examination power contained in this text. Source.

Note 191

Robert Dallek, interview with Terry Gross, Fresh Air, May 14, 2003, “Author Robert Dallek, on John F. Kennedy.” Transcript; opening medical-history and crisis-performance discussion. Interview about An Unfinished Life, not a book-page citation. Source.

Note 192

Candice Millard, The Diane Rehm Show, September 19, 2011, “Candice Millard: Destiny of the Republic.” Transcript; broadcaster clock 12:27:20–12:27:53, 12:32:47 and 12:34:26–12:34:59. Times are broadcast clock labels, not elapsed recording times. Source.

Note 193

Matthew Algeo, NPR interview with Steve Inskeep, syndicated by WLRN, July 6, 2011, “A Yacht, A Mustache: How A President Hid His Tumor.” Interview-based article, section “The Press Gets The Scoop”; not a verbatim transcript. Source.

Note 194

Robert H. Ferrell, C-SPAN Booknotes, The Strange Deaths of President Harding, January 12, 1997. Transcript; question “How did he die?” Historical interpretation, not definitive clinical confirmation. Source.

Note 195

Robert E. Gilbert, C-SPAN Booknotes, The Mortal Presidency: Illness and Anguish in the White House, January 24, 1993. Transcript; Coolidge discussion and question about source information. Source.

Note 196

Joshua Wolf Shenk, “The True Lincoln,” History News Network, June 28, 2005, reproducing author writing identified with the July 4, 2005 TIME issue. Author article, not an interview. Source.

Note 197

Jake Tapper, interview with Terry Gross, Fresh Air, May 20, 2025, discussing Original Sin. Transcript; questions on access, post-election candor, policy decision-making and autopen. Source.

Note 198

American College of Radiology, “ACR Statement on Screening Total Body MRI,” April 17, 2023; accessed September 7, 2026. Professional position on routine asymptomatic screening, not an evaluation of a presidential pilot. Source.

Note 199

Chandra, Bilva, et al. Reducing Risks Posed by Synthetic Content: An Overview of Technical Approaches to Digital Content Transparency. NIST AI 100-4, November 20, 2024. Publication overview and abstract accessed September 7, 2026. Supports the listed technical approaches, not clinical assessment or endorsement of the author’s presidential-access proposal. Source

Note 200

U.S. Department of Health and Human Services. Summary of the HIPAA Privacy Rule. Sections on required-by-law disclosures and authorization. Accessed September 7, 2026. Overview rather than comprehensive legal advice; presidential review authority and constitutional questions require separate analysis. Source Supplement to note 200 (September 9, 2026): HHS, Authorizations, FAQ 474, on revocation and its exceptions. Source . This supports the Chapter 12 authorization qualification; it does not establish authority for compulsory presidential review.

Six research tools

Use these companion exercises to record a question, separate evidence from interpretation, and identify what remains unknown.

Tool A

Read the evidence in layers

Separate what happened from what someone inferred.

Start with one precise statement. A medical memorandum, an interview, a retrospective account and a proposed policy can all matter, but each answers a different question. Record who created the source, when it was created, and what the author could directly know. An interview is direct evidence of what the speaker said; it may be indirect evidence of the event being described.

Keep observation, attributed reporting, interpretation and proposal in separate lines. Then write the strongest conclusion the evidence supports and one conclusion it does not support. A disclosed diagnosis does not establish earlier functional impairment. Absence of a public record does not by itself establish concealment.

  1. What exact claim am I examining?
  2. What is the original source, date and locator?
  3. What did this source directly observe or record?
  4. Which parts are interpretation or proposal?
  5. What remains unknown, and what evidence would change my conclusion?
Download the worksheet (PDF)

Tool B

Compare two sources

Find out whether agreement is independent corroboration.

Two accounts may appear to corroborate one another while relying on the same interview, unnamed witness or earlier article. Follow each account backward before counting their agreement as independent support. Record exact editions or dated versions; a summary of a book is not a page citation to that book.

Disagreement is useful when it reveals differences in access, timing or interpretation. Describe the disagreement in terms both sources would recognize. Do not resolve it by counting headlines or choosing the more dramatic version. Preserve a narrow unresolved conclusion when the record cannot settle the matter.

  1. Source A: creator, date, title and exact locator
  2. Source B: creator, date, title and exact locator
  3. Do they rely on the same witness or underlying record?
  4. Where do they agree, differ, or qualify the claim?
  5. What can I conclude without choosing an unsupported version?
Download the worksheet (PDF)

Tool C

Build a two-date timeline

Keep the event date separate from the disclosure date.

Historical understanding changes when later records become available. For each entry, record the date of the event and the date the information became public. If either date is uncertain, keep a range or write unknown. Do not force a precise date merely to complete the timeline.

Add what was knowable at the time. Distinguish a later interpretation from a contemporary finding, and label testimony as testimony. In medical cases, a later grade, stage or diagnosis does not supply the date when a disease began or establish what any particular person knew earlier.

  1. Event or reported occurrence and its date or range
  2. When did this information become public?
  3. What contemporary record supports it?
  4. What later source changes or qualifies the account?
  5. What was knowable then, and what remains uncertain now?
Download the worksheet (PDF)

Tool D

Read an interview closely

Trace the speaker’s knowledge and preserve qualifications.

Record the interviewer, speaker, program, date and locator. Use elapsed audio time only when that is what the source supplies; some transcripts use broadcast-clock times. Identify whether you inspected the recording, an actual transcript or an article summarizing an interview.

Keep the question with the answer when context affects meaning. Separate the speaker’s own observation from a witness’s account and the speaker’s interpretation. Capture meaningful qualifications and corrections. A confident delivery does not establish the underlying event, and an edited excerpt may omit a limitation present in the complete interview.

  1. Program, speaker, interviewer, date and locator
  2. Did I inspect recording, transcript, or interview summary?
  3. What question was the speaker answering?
  4. What could the speaker know directly, and what was attributed?
  5. Which qualification, disagreement or missing context must travel with the quotation?
Download the worksheet (PDF)

Tool E

Check a digital appearance

Distinguish an authorized message from live participation.

A message can be authorized without being delivered live. The book treats authorization, identity, presence and functional capacity as separate questions. Begin with the original channel and provenance, then look for independent records and whether there was unscripted interaction. Do not diagnose a person from an appearance.

A signature or provenance record can help establish origin or integrity; it does not establish the truth of a statement or the speaker’s cognition. Missing provenance does not prove fabrication. Document uncertainty and seek an independent confirmation channel before treating a clip as a reliable record of a live exchange.

  1. Original publisher, URL, date and preserved context
  2. Was this live interaction, a recording, or an authorized prepared message?
  3. What independent recording or witness is available?
  4. What origin or integrity evidence can I actually inspect?
  5. What is verified, unverified, or outside what this material can establish?
Download the worksheet (PDF)

Tool F

Stress-test a reform proposal

Apply the same standard when political power changes hands.

Identify the historical failure a proposal is meant to address, then separate the desired result from the legal authority and practical mechanism needed to achieve it. Ask who requests information, who evaluates it, who can contest a finding and who has lawful power to act. Medical findings and constitutional authority are different parts of that process.

Test both kinds of error: failing to recognize real inability and wrongly challenging a capable leader. Consider privacy, accommodations, independent confirmation, dissent, recovery, appeal and political capture. A realistic simulation or plausible institution is not automatically validated. State what a pilot would have to demonstrate and which result would justify revising the proposal.

  1. Which documented failure does the proposal address?
  2. What authority exists, and what would require new law or another process?
  3. Who evaluates evidence, who decides, and who can challenge the result?
  4. How does it protect both an impaired leader and a capable leader?
  5. Would I accept this rule for the other party, and what pilot result would change it?
Download the worksheet (PDF)

Index of the 40 figures

This caption index matches the revised manuscript. It identifies the book’s figures; it is not a separately verified figure-source or permissions ledger. Interpret proposed systems as proposals, and consult the corresponding chapters and notes for context.

  1. Figure 1.1 — The Republic Assumed Visibility. A two-era comparison showing early-republic visibility versus modern managed opacity.
  2. Figure 2.1 — The Presidential Secrecy Timeline. Selected episodes of presidential-health opacity; the evidence and degree of concealment differ by case.
  3. Figure 3.1 — Chronic Illness and Acute Crisis Require Different Tracks. A historical comparison separating chronic-function monitoring from acute-incapacity continuity procedures.
  4. Figure 4.1 — The 1988 Medical Cascade. A clinical timeline of aneurysm rupture, neurosurgery, pulmonary embolism, recovery, and long-term risk questions.
  5. Figure 5.1 — What Presidential Capacity Requires. A capacity-domain map for the cognitive presidency.
  6. Figure 5.2 — Capacity Is Not Diagnosis. A two-track diagram separating disease labels from functional capacity assessment.
  7. Figure 5.3 — Presence Is Not Performance. A president may work at the White House or elsewhere. Location does not establish capacity, and the absence of verification does not itself establish inability. Reliable assessment requires evidence of actual function.
  8. Figure INT I.1 — Screening Is Not Capacity Evaluation. A three-layer model separating brief screening, core capacity domains, and performance under realistic presidential load.
  9. Figure INT I.2 — The Presidential Simulation. A seven-stage crisis simulation testing retention, comparison, adaptation, authorization, and communication.
  10. Figure INT I.3 — After an Abnormal Result. Assess urgency first. Immediate inability may require urgent constitutional action; a nonemergency finding calls for confirmation and reassessment. An abnormal test alone does not establish inability.
  11. Figure 6.1 — Population PSA Guidelines vs Presidential Surveillance. A side-by-side comparison of population screening logic and high-consequence presidential surveillance logic.
  12. Figure 6.2 — ADT and Capacity-Relevant Effects. A cautious map of treatment effects that may matter for presidential function when androgen-deprivation therapy is used.
  13. Figure 6.3 — The Confidentiality Bottleneck. A structural flow showing how privacy, privilege, consent, and lawful process determine whether capacity-relevant information can be reviewed.
  14. Figure 7.1 — Grade and Stage Cannot Date the Beginning. A prostate-cancer timeline showing why grade and stage cannot reconstruct the date of biological onset.
  15. Figure 7.2 — PSA Is the Signal, MRI Is the Map, Biopsy Is the Proof. A three-part distinction between biomarker signal, imaging localization, and pathological confirmation.
  16. Figure 7.3 — Presidential Urology Review. The proposed review connects the clinical record, protected assessment, and a limited functional report. Relevant symptoms, prior testing, medication effects, treatment burden, and reassessment triggers remain part of the clinical review.
  17. Figure 7.4 — Protected Disclosure Reduces Medical Leverage. A national-security comparison showing how protected review and limited disclosure reduce coercive leverage.
  18. Figure 8.1 — The Protective Architecture. A model of the incentives that can surround and buffer a president under capacity concern.
  19. Figure 8.2 — The Incentive to Hide. A decision-pressure map showing how opacity can arise from predictable incentives.
  20. Figure 8.3 — Party Self-Harm Timeline. A campaign-cycle timeline showing how delayed truth can compress replacement options.
  21. Figure 10.1 — Press Bubble and Controlled Access. A media-access funnel showing how controlled exposure can filter public perception.
  22. Figure 10.2 — Compassion Is Not Accountability. A balanced scale showing compassion for the patient and accountability for the office.
  23. Figure 11.1 — The Two-Direction Media Error Audit. A balanced newsroom audit of understatement and overstatement in presidential-health coverage.
  24. Figure 11.2 — The Presidential Health Evidence Ladder. A starting guide to source types; evidentiary weight also depends on the claim, directness, context, and independent corroboration.
  25. Figure 12.1 — The Private Doctor and the Public Certifier. A two-role model separating confidential clinical care from accountable public certification.
  26. Figure 12.2 — Disclosure and Immunity. Patient authorization, a witness’s personal privilege, and a lawful immunity order are distinct legal questions. Use and derivative-use immunity restricts criminal use of compelled evidence; it is not a pardon. [104–105]
  27. Figure 13.1 — The Verification Gap. Acute and gradual changes can require assessment of function. Section 4 is not limited to sudden emergencies; a diagnosis alone does not determine inability. [100]
  28. Figure 13.2 — Who Should Decide? Oversight Models. A comparison of the current constitutional actors, an advisory clinical board, and a possible Section 4 “other body.”
  29. Figure INT II.1 — Guardrails Against Board Capture. Six institutional safeguards protecting an independent medical review board from partisan capture.
  30. Figure INT II.2 — The Secure Medical Compartment. Nested evidence compartments separating the complete clinical record from limited public certification.
  31. Figure INT II.3 — Due Process and Independent Confirmation. A protected pathway for notice, evidence access, independent counsel, confirmation, and a reviewable record.
  32. Figure INT II.4 — Inability and Transfer. Temporary and persistent inability require proportionate assessment. Section 4 provides for an Acting President, not permanent removal, and preserves constitutional procedures for contest and return. [100]
  33. Figure 14.1 — Proposed Review Commission. Clinical evidence and independent medical assessment inform a proposed three-member judicial process review. Both sitting-Justice and retired-judge designs require constitutional analysis; neither is an existing presidential-health authority. [97–100]
  34. Figure 14.2 — The Sealed Accuracy Hearing. A sealed review process for testing the accuracy and completeness of a public health certification.
  35. Figure 15.1 — The Presidential Health Review Board. A structural diagram of the proposed presidential-health oversight body.
  36. Figure 15.2 — Capacity Under Pressure. Cyberattacks, market disruption, and security crises are illustrative demands on understanding, decision-making, and authorization. The diagram asserts no fixed response times.
  37. Figure 15.3 — Closed-Door Medical Review Workflow. A workflow from trigger event to secure assessment, board review, and limited certification.
  38. Figure 15.4 — Presidential Health Disclosure Tiers. A privacy-respecting model that scales disclosure to functional consequence.
  39. Figure 16.1 — Proposed Reform Roadmap. Initial drafting, institutional commitment, a 2027 pilot target, and readiness before consequential nominating contests are proposed milestones. Phases may overlap; dates do not record completed action.
  40. Figure 16.2 — The Public Implementation Dashboard. An institutional-readiness dashboard that excludes private medical information and candidate health scores.

Keep a copy

Edition notes

This archive incorporates the revised source title and link for note 97 and the additional authorization-revocation source in note 200. All 200 original note numbers remain intact. The figure index follows the current 40-caption sequence.

The research tools are companion exercises. They do not establish a diagnosis, verify an allegation, or confer legal authority on a proposal. Printed publication and final proof review remain separate from this online companion.

← About Behind the Curtain